Results 221 to 230 of about 1,382,625 (239)

Tertiary lymphoid structures in cancer: their development, composition, clinical prognosis, and the drivers of the anti-tumor responses. [PDF]

Mol Biomed
Dou ZC, Shi YC, Meng K, Wang JR, Liang XH, Tang YL.   +5 more
europepmc   +1 more source

Mitochondrial OPerA: tuning retrograde signaling and empowering intratumoral cDC1s. [PDF]

Life Metab
Kushwaha B, Wang R.
europepmc   +1 more source

Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Prognostic Significance, Predictive Value, and Emerging Directions for Clinical Implementation. [PDF]

Cancers (Basel)
Eiamprapaporn P, Venegas Mata C, Nandani R, Susiriwatananont T, Knutson KL, Chumsri S.   +5 more
europepmc   +1 more source

CRISPR-Engineered CAR-T Cell Therapy for Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma: A Review of Emerging Therapeutic Prospects. [PDF]

Rev Med Virol
Allehyani N, Alissa M, Alghamdi A, Alshehri MA, Abusalim GS, Alhegaili AS, Juraybi TN, Alsuwat MA.   +7 more
europepmc   +1 more source

Adoptive Cellular Immunotherapy with CD19-Specific T Cells

Klinische Padiatrie, 2005
BACKGROUND: No effective therapeutic modalities exist for the treatment of relapsed high risk acute lymphoblastic leukemia (ALL). Adoptive cellular immunotherapy by transfusion of polyclonal donor lymphocytes is not always effective and is limited by ...
Claudia Rossig, Bianca Altvater, J Vormoor   +2 more
exaly   +6 more sources

Some of the next articles are maybe not open access.

Related searches:

Cellular Immunotherapy in Gastric Cancer: Adoptive Cell Therapy and Dendritic Cell-Based Vaccination

Immunotherapy, 2022
Amir Hossein Faghfouri, Elnaz Faghfuri, Mahdi Abdoli Shadbad   +2 more
exaly  

A Review of Cancer Immunotherapy Toxicity II: Adoptive Cellular Therapies, Kinase Inhibitors, Monoclonal Antibodies, and Oncolytic Viruses

Journal of Medical Toxicology, 2021
Neeraj Chhabra
exaly  

Low-Dose Ionizing Radiation Induces Direct Activation of Natural Killer Cells and Provides a Novel Approach for Adoptive Cellular Immunotherapy

Cancer Biotherapy and Radiopharmaceuticals, 2014
Jiuwei Cui, Dehai Yu, Haofan Jin
exaly  

IL-2 Enhances Standard IFNγ/LPS Activation of Macrophage Cytotoxicity to Human Ovarian Carcinoma in Vitro: A Potential for Adoptive Cellular Immunotherapy

Gynecologic Oncology, 1999
K S Raju, G D Wilbanks, K Shanti Raju
exaly  

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly